Remote Cognitive Screening in Parkinson Disease: Validating the ORCA-PD Tool

Parkinson disease (PD) is predominantly recognized for its motor symptoms, yet covert cognitive decline affects many patients long before dementia occurs. Traditional in-person cognitive testing presents substantial barriers: severe mobility impairments make traveling to clinics difficult, expert evaluations suffer from long waitlists, and screening tools like the Montreal Cognitive Assessment (MoCA) rely heavily on fine motor tasks like drawing, which can confound cognitive scores.

In a mixed-methods study published in the Journal of Medical Internet Research, researcher Avigail Lithwick Algon and colleagues at Tel Aviv University address these barriers with the development and validation of the Online Rapid Cognitive Assessment for Parkinson’s Disease (ORCA-PD).

Designing a Remote, Motor-Minimized Screening Tool

ORCA-PD is a 15-minute, fully self-administered web-based assessment designed to capture PD-specific cognitive changes remotely while reducing physical demands:

• Low Motor Burden: Replaces complex drawing or high-precision mouse tracking with simple two-choice keyboard responses to prevent motor tremors from distorting cognitive measurements.
• Targeted Cognitive Tasks: Incorporates 8 brief measures (5 performance tasks and 3 questionnaires) chosen for high sensitivity to PD based on prior meta-analyses, including Digit Span variants, Line Orientation Matching, and Alternate Task Switching.
• High Usability Across Regions: In a trial of 112 participants spanning more than 30 geographical locations, the tool achieved a 93% completion rate, with median user satisfaction scores of 4 to 5 out of 5.

Preliminary Validation and Discriminative Power

To establish validity, researchers evaluated ORCA-PD against standard clinical benchmarks:

• Convergent Validity with MoCA: ORCA-PD scores correlated significantly with online-administered MoCA scores (rho = 0.45, P < .001), confirming that it measures overlapping cognitive domains without requiring a clinician's presence.
• Independence from Motor Severity: ORCA-PD scores showed no correlation with motor impairment scores on the MDS-UPDRS III, demonstrating that the test accurately isolates cognitive function from physical symptom severity.
• Sensitivity to Cognitive Stages: The tool successfully differentiated neurotypical controls from participants with PD (beta = 4.18, P = .048), and distinguished PD patients without mild cognitive impairment (MCI) from those with PD-MCI (beta = 7.22, P = .046).

The authors chose the Journal of Medical Internet Research to publish this work because of the journal's focus on digital health tools, remote neuropsychological testing, and scalable telehealth innovations. As neurological care increasingly moves toward decentralized models, ORCA-PD offers a validated, accessible solution for early cognitive screening and continuous home monitoring between clinic visits.

Interested in remote cognitive monitoring for Parkinson disease? Watch the video featuring Avigail Lithwick Algon and read the full study to explore the task design, statistical models, and clinical applications.